Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $4.06 in the prior trading day, Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $4.13, up 1.72%. In other words, the price has increased by $1.72 from its previous closing price. On the day, 1.08 million shares were traded.
Ratios:
Our goal is to gain a better understanding of TERN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.99 and its Current Ratio is at 32.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on October 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $82.
On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.Jefferies initiated its Buy rating on June 07, 2023, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 30 ’24 when Jung Melita Sun bought 2,250 shares for $5.11 per share. The transaction valued at 11,498 led to the insider holds 2,250 shares of the business.
Burroughs Amy L. bought 510 shares of TERN for $2,606 on Nov 30 ’24. The Chief Executive Officer now owns 19,609 shares after completing the transaction at $5.11 per share. On Jan 02 ’25, another insider, Kuriakose Emil, who serves as the Chief Medical Officer of the company, sold 4,481 shares for $5.71 each. As a result, the insider received 25,607 and left with 54,269 shares of the company.
Stock Price History:
Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is -21.79%, while the 200-Day Moving Average is calculated to be -39.77%.
Shares Statistics:
A total of 84.92M shares are outstanding, with a floating share count of 62.00M. Insiders hold about 27.00% of the company’s shares, while institutions hold 80.78% stake in the company.
Earnings Estimates
The performance of Terns Pharmaceuticals Inc (TERN) in the stock market is under the watchful eye of 8.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.27 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.13 and -$1.24 for the fiscal current year, implying an average EPS of -$1.19. EPS for the following year is -$1.32, with 8.0 analysts recommending between -$1.13 and -$1.48.
